Arkolith/Insider Trading/SGTX/Form 4

Ruffolo Robert R

DirectorSigilon Therapeutics, Inc. (SGTX) · full profile →Form 4 · filed Jul 2, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$70K
Net Open-Market Flow
-$70K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2021Option exercise(M)7K$0.57$4K7K
Jul 1, 2021Sell(S)7K$10.36$70K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2021Option exercise(M)7K—$049K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-21-003398) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML